Its clinical significance has been characterized in chronic kidney disease, where the upregulation of Myostatin in skeletal muscle was identified as one major pathway responsible for muscle wasting in patients with advanced chronic kidney disease [5,6]. The gene discussed is MSTN; the disease is chronic kidney disease.